Scarica l'app Stockscreener
3.73
0.27%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - AOL.com
GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - marketbeat.com
GDRX Maintained by UBS -- Price Target Raised to $3.75 - GuruFocus
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook - Yahoo Finance
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise - Yahoo Finance
GoodRx (NASDAQ:GDRX) Trading Down 5.1%What's Next? - marketbeat.com
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope (NASDAQ:GDRX) - Seeking Alpha
Why Is GoodRx Holdings (GDRX) Putting Finance And Strategy Under Justin Fengler? - Sahm
GDRX Maintained by Citigroup -- Price Target Raised to $5.00 - GuruFocus
GoodRx (NASDAQ:GDRX) Stock Price Expected to Rise, Citigroup Analyst Says - marketbeat.com
GDRX Maintained by TD Cowen -- Price Target Raised to $5.00 - GuruFocus
GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook - Yahoo Finance UK
GOODRX HOLDINGS, INC. : CITIGROUP RAISES TARGET PRICE TO $5 FROM $4 - Bitget
GDRX Maintains Overweight by Wells Fargo -- Price Target Raised to $5.00 - GuruFocus
GoodRx Holdings Price Target Raised to $5.00/Share From $3.50 by Wells Fargo - Moomoo
Prescription savings giant GoodRx could be opening office at The Pearl - The Business Journals
GoodRx Holdings Inc (GDRX) Stock Analysis & Forecast - TradingKey
GoodRx Holdings Inc (GDRX) Stock News Today - TradingKey
Wells Fargo & Company Boosts GoodRx (NASDAQ:GDRX) Price Target to $5.00 - MarketBeat
GoodRx Holdings Inc (GDRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GoodRx Holdings, Inc. Stock 12‑Month Price Target Raised to $3.7 - TradingView
Morgan Stanley Adjusts Price Target on GoodRx to $4 From $3, Maintains Equalweight Rating - marketscreener.com
Earnings call transcript: GoodRx lifts 2026 outlook after Q2 revenue beat - Investing.com Canada
Transcript : GoodRx Holdings, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
GoodRx Lets Customers Shop Where They Want, CEO Says - marketscreener.com
GoodRx Q2 Earnings Call Highlights - marketbeat.com
GoodRx (NASDAQ:GDRX) Stock Price Up 15.7%Here's Why - MarketBeat
GDRX: Pharma Direct and subscriptions drove Q2 outperformance, leading to raised 2026 guidance - TradingView
GoodRx Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
GDRX Looks 42.2% Undervalued on GF Value™ - GuruFocus
GDRX SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus
GoodRx (NASDAQ:GDRX) Posts Earnings Results, Hits Estimates - MarketBeat
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates - Yahoo Finance
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Is GoodRx Holdings Inc (GDRX) Undervalued After Q2 Earnings? EPS - GuruFocus
GoodRx (NASDAQ:GDRX) Reports Upbeat Q2 CY2026, Stock Soars - Barchart.com
GoodRx Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Aug 05 (Reuters)GoodRx Holdings Q2 Revenue - Moomoo
GDRX: Pharma Direct and subscription growth drove raised 2026 guidance despite lower transactions - tradingview.com
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q2 EPS; Offers Guidance - StreetInsider
GoodRx Reports Second Quarter 2026 Results - marketscreener.com
GoodRx Holdings, Inc. 2026: Revenue $200.41M, EPS $0.02— 10-Q Summary - TradingView
GoodRx Holdings (NASDAQ: GDRX) elevates Justin Fengler to CFO role - Stock Titan
GoodRx Holdings (NASDAQ: GDRX) pivots as Rx revenue falls 26% - Stock Titan
GoodRx Holdings, Inc. Announces Management Changes - marketscreener.com
GoodRx Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GoodRx (NASDAQ: GDRX) Q2 2026 revenue hits $200M as mix shifts - Stock Titan
BRIEF-GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million - TradingView
GoodRx Holdings, Inc. Raises Earnings Guidance for the Year 2026 - marketscreener.com
GoodRx earnings up next: Can subscriptions reverse revenue slide? - Investing.com
GoodRx earnings up next: Can subscriptions reverse revenue slide? By Investing.com - Investing.com Nigeria
GDRX Q2'26 Earnings: EPS estimate is 0.08 USD - TradingView
InvestingPro Fair Value analysis delivers 69% return on GoodRx By Investing.com - Investing.com
GoodRx Earnings: What To Look For From GDRX - Barchart.com
GoodRx Holdings Inc expected to post earnings of 8 cents a shareEarnings Preview - TradingView
Akebia Therapeutics And 2 Promising Penny Stocks To Watch - simplywall.st
GDRX Q2'26 Earnings: revenue estimate is 193.23M USD - TradingView
GoodRx Holdings, Inc. Revenue Breakdown – NASDAQ:GDRX - TradingView
GoodRx Holdings Inc (GDRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GoodRx Holdings Inc (GDRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
GoodRx Holdings Inc. (GDRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
GDRX|GoodRx Holdings Inc|Price:3.065|Chg%:+0.105 - TradingKey
GoodRx Holdings Inc (GDRX) Income Statement - TradingKey
GoodRx Holdings Inc (GDRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GoodRx Holdings Inc (GDRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
1.10%
6.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):